Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 8, 38

Microbiome Changes: An Indicator of Parkinson's Disease?


Microbiome Changes: An Indicator of Parkinson's Disease?

Caroline Haikal et al. Transl Neurodegener.


Parkinson's disease is characterized by dopaminergic neuron loss and intracellular inclusions composed mainly of alpha synuclein (α-syn), but the mechanism of pathogenesis is still obscure. In recent years, more attention has been given to the gut as a key player in the initiation and progression of PD pathology. Several studies characterizing changes in the microbiome, particularly the gut microbiome, have been conducted. Although many studies found a decrease in the bacterial family Prevotellaceae and in butyrate-producing bacterial genera such as Roseburia and Faecalibacteria, and an increase in the genera Akkermansia many of the studies reported contradictory findings. In this review, we highlight the findings from the different studies and reflect on the future of microbiome studies in PD research.

Keywords: Gut; Inflammation; Intestinal microbiota; Parkinson’s disease; Protein aggregation.

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Similar articles

See all similar articles


    1. Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003;110:517–536. doi: 10.1007/s00702-002-0808-2. - DOI - PubMed
    1. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599–614. doi: 10.1111/j.1365-2990.2007.00874.x. - DOI - PubMed
    1. Holmqvist S, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805–820. doi: 10.1007/s00401-014-1343-6. - DOI - PubMed
    1. Kim S, et al. Transneuronal propagation of pathologic alpha-Synuclein from the gut to the brain models Parkinson's disease. Neuron. 2019;103:627–641. doi: 10.1016/j.neuron.2019.05.035. - DOI - PMC - PubMed
    1. Svensson E, et al. Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol. 2015;78:522–529. doi: 10.1002/ana.24448. - DOI - PubMed

LinkOut - more resources